Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 08/12/2011
PIL Istin

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/12/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 10/11/2011 and displayed until 08/12/2011
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to Marketing Authorisation Holder
  • Change to dosage and administration
Updated on 29/03/2010 and displayed until 10/11/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 25/01/2010 and displayed until 29/03/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 29/01/2009 and displayed until 25/01/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 14/01/2009 and displayed until 29/01/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 21/11/2008 and displayed until 14/01/2009
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 27/05/2008 and displayed until 21/11/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 23/01/2006 and displayed until 27/05/2008
Reasons for adding or updating:
  • Change of active ingredient
  • Change to appearance of the medicine
  • Change to date of revision
Updated on 28/10/2004 and displayed until 23/01/2006
Reasons for adding or updating:
  • Change from the BAN of the active substance to the rINN
  • Change to storage instructions
  • Change to side-effects
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 26/05/2000 and displayed until 28/10/2004
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   amlodipine besilate